GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15729 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-24

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diabetes Treatment With Glucobay in Combination With Metformin

NCT01612741

Type 2 Diabetes Mellitus

COMPLETED

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients

NCT01219582

Type 2 Diabetes

COMPLETED

Diabetes Treatment With Glucobay in Combination With Sulfonylurea

NCT01613105

Type 2 Diabetes Mellitus

COMPLETED

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

NCT00970528

Diabetes Mellitus, Type 2

COMPLETED PHASE4

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice

NCT01915264

Diabetes Mellitus, Type 2

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Acarbose (Glucobay, BAYG5421)

Intervention Type DRUG

Patients with diabetes type 2 newly treated with Glucobay

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acarbose (Glucobay, BAYG5421)

Patients with diabetes type 2 newly treated with Glucobay

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with untreated or pretreated diabetes mellitus or patients for which acarbose is indicated and without acarbose treatment within the last three months before study inclusion. The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bayer Study Director

Role: STUDY_DIRECTOR

Bayer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Multiple Locations, , Algeria

Site Status

Multiple Locations, , Bosnia and Herzegovina

Site Status

Multiple Locations, , Cambodia

Site Status

Multiple Locations, , China

Site Status

Multiple Locations, , Hong Kong

Site Status

Multiple Locations, , India

Site Status

Multiple Locations, , Indonesia

Site Status

Multiple Locations, , Malaysia

Site Status

Multiple Locations, , Moldova

Site Status

Multiple Locations, , Pakistan

Site Status

Multiple Locations, , Philippines

Site Status

Multiple Locations, , Russia

Site Status

Multiple Locations, , Singapore

Site Status

Multiple Locations, , South Korea

Site Status

Multiple Locations, , Thailand

Site Status

Multiple Locations, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Algeria Bosnia and Herzegovina Cambodia China Hong Kong India Indonesia Malaysia Moldova Pakistan Philippines Russia Singapore South Korea Thailand Vietnam